Brain Tumor Reports
54

Volume 19 Supplement 5
May 2017


Home > Publications > Brain Tumor Reports > Volume 19, Year 2017 > Supplement 5, May


CONTENTS



BRAIN TUMORS
GLIOBLASTOMA
GLIOMAS
INTRAMEDULLARY SPINAL CORD TUMORS
MEDULLOBLASTOMA
PILOCYTIC ASTROCYTOMA
TUMORS OF THE SELLAR REGION





BRAIN TUMORS



Combs SE.
Does Proton Therapy Have a Future in CNS Tumors?
Curr Treat Options Neurol. 2017 Mar;19(3):12. doi: 10.1007/s11940-017-0447-4.
Source | Abstract | Full text | Similar articles




Marosi C, Preusser M.
Milestones of the last 10 years: CNS cancer.
Memo. 2017;10(1):18-21. doi: 10.1007/s12254-016-0309-x. Epub 2017 Jan 25
Source | Abstract | Full text | Similar articles




van den Bent MJ, Weller M, Wen PY, Kros JM, Aldape K, Chang S.
A clinical perspective on the 2016 WHO brain tumor classification and routine molecular diagnostics.
Neuro Oncol. 2017 Feb 21. doi: 10.1093/neuonc/now277. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





GLIOBLASTOMA



Azoulay M, Santos F, Shenouda G, Petrecca K, Oweida A, Guiot MC, Owen S, Panet-Raymond V, Souhami L, Abdulkarim BS.
Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution.
J Neurooncol. 2017 Apr 3. doi: 10.1007/s11060-017-2383-2. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Ben Nsir A, Gdoura Y, Thai QA, Zhani Kassar A, Hattab N, Jemel H.
Intraventricular Glioblastomas.
World Neurosurg. 2016 Apr;88:126-31. doi: 10.1016/j.wneu.2015.12.079. Epub 2016 Jan 8.
Source | Abstract | Full text | Similar articles




Blumenthal DT, Gorlia T, Gilbert MR, Kim MM, Burt Nabors L, Mason WP, Hegi ME, Zhang P, Golfinopoulos V, Perry JR, Hyun Nam D, Erridge SC, Corn BW, Mirimanoff RO, Brown PD, Baumert BG, Mehta MP, van den Bent MJ, Reardon DA, Weller M, Stupp R.
Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG.
Neuro Oncol. 2017 Mar 24. doi: 10.1093/neuonc/nox025. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Ellingson BM, Chung C, Pope WB, Boxerman JL, Kaufmann TJ.
Pseudoprogression, radionecrosis, inflammation or true tumor progression? challenges associated with glioblastoma response assessment in an evolving therapeutic landscape.
J Neurooncol. 2017 Apr 5. doi: 10.1007/s11060-017-2375-2. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Gahrmann R, van den Bent M, van der Holt B, Vernhout RM, Taal W, Vos M, de Groot JC, Beerepoot LV, Buter J, Flach ZH, Hanse M, Jasperse B, Smits M.
Comparison of 2D (RANO) and volumetric methods for assessment of recurrent glioblastoma treated with bevacizumab-a report from the BELOB trial.
Neuro Oncol. 2017 Feb 13. doi: 10.1093/neuonc/now311. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Huang R.
Response assessment in high-grade glioma: tumor volume as endpoint.
Neuro Oncol. 2017 Mar 30. doi: 10.1093/neuonc/nox035. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Kolakshyapati M, Adhikari RB, Karlowee V, Takayasu T, Nosaka R, Amatya VJ, Takeshima Y, Akiyama Y, Sugiyama K, Kurisu K, Yamasaki F.
Nonenhancing peritumoral hyperintense lesion on diffusion-weighted imaging in glioblastoma: a novel diagnostic and specific prognostic indicator.
J Neurosurg. 2017 Mar 31:1-12. doi: 10.3171/2016.10.JNS161694. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Lombardi G, Pace A, Pasqualetti F, Rizzato S, Faedi M, Anghileri E, Nicolotto E, Bazzoli E, Bellu L, Villani V, Fabi A, Ferrazza P, Gurrieri L, Dall'Agata M, Eoli M, Della Puppa A, Pambuku A, D'Avella D, Berti F, Rudà R, Zagonel V.
Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter retrospective study of AINO (Italian Association of Neuro-Oncology).
J Neurooncol. 2015 Nov;125(2):359-67. doi: 10.1007/s11060-015-1923-x. Epub 2015 Sep 30.
Source | Abstract | Full text | Similar articles




Minniti G, Scaringi C, Lanzetta G, Terrenato I, Esposito V, Arcella A, Pace A, Giangaspero F, Bozzao A, Enrici RM.
Standard (60 Gy) or short-course (40 Gy) irradiation plus concomitant and adjuvant temozolomide for elderly patients with glioblastoma: a propensity-matched analysis.
Int J Radiat Oncol Biol Phys. 2015 Jan 1;91(1):109-15. doi: 10.1016/j.ijrobp.2014.09.013. Epub 2014 Oct 25.
Source | Abstract | Full text | Similar articles




Minniti G, Scaringi C, Baldoni A, Lanzetta G, De Sanctis V, Esposito V, Enrici RM.
Health-related quality of life in elderly patients with newly diagnosed glioblastoma treated with short-course radiation therapy plus concomitant and adjuvant temozolomide.
Int J Radiat Oncol Biol Phys. 2013 Jun 1;86(2):285-91. doi: 10.1016/j.ijrobp.2013.02.013.
Source | Abstract | Full text | Similar articles




Minniti G, Lanzetta G, Scaringi C, Caporello P, Salvati M, Arcella A, De Sanctis V, Giangaspero F, Enrici RM.
Phase II study of short-course radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma.
Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):93-9. doi: 10.1016/j.ijrobp.2011.06.1992. Epub 2011 Nov 11.
Source | Abstract | Full text | Similar articles




Muni R, Minniti G, Lanzetta G, Caporello P, Frati A, Enrici MM, Marchetti P, Enrici RM.
Short-term radiotherapy followed by adjuvant chemotherapy in poor-prognosis patients with glioblastoma.
Tumori. 2010 Jan-Feb;96(1):60-4.
Source | Abstract | Full text | Similar articles




Skardelly M, Dangel E, Gohde J, Noell S, Behling F, Lepski G, Borchers C, Koch M, Schittenhelm J, Bisdas S, Naumann A, Paulsen F, Zips D, von Hehn U, Ritz R, Tatagiba MS, Tabatabai G.
Prolonged Temozolomide Maintenance Therapy in Newly Diagnosed Glioblastoma.
Oncologist. 2017 Mar 30. pii: theoncologist.2016-0347. doi: 10.1634/theoncologist.2016-0347. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Srinivasan VM, Ferguson SD, Lee S, Weathers SP, Kerrigan BCP, Heimberger AB.
Tumor Vaccines for Malignant Gliomas.
Neurotherapeutics. 2017 Apr;14(2):345-357. doi: 10.1007/s13311-017-0522-2.
Source | Abstract | Full text | Similar articles





GLIOMAS



GLIOMATOSIS CEREBRI


Burger MC, Mildenberger IC, Wagner M, Mittelbronn M, Steinbach JP, Bähr O.
Bevacizumab for Patients with Recurrent Gliomas Presenting with a Gliomatosis Cerebri Growth Pattern.
Int J Mol Sci. 2017 Mar 29;18(4). pii: E726. doi: 10.3390/ijms18040726.
Source | Abstract | Full text | Similar articles




Carroll KT, Hirshman B, Ali MA, Alattar AA, Brandel MG, Lochte B, Lanman T, Carter B, Chen CC.
Management and Survival Patterns of Patients with Gliomatosis Cerebri: a SEER-based Analysis.
World Neurosurg. 2017 Mar 30. pii: S1878-8750(17)30426-6. doi: 10.1016/j.wneu.2017.03.103. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




HIGH-GRADE GLIOMAS


Ansari M, Mosalaei A, Ahmadloo N, Rasekhi A, Geramizadeh B, Razmkon A, Anvari K, Afarid M, Dadras A, Nafarieh L, Mohammadianpanah M, Nasrolahi H, Hamedi SH, Omidvari S, Nami M.
A comprehensive approach in high-grade glioma management: position statement from the Neuro-Oncology Scientific Club (NOSC), Shiraz, Iran.
Ger Med Sci. 2017 Feb 28;15:Doc05. doi: 10.3205/000246. eCollection 2017.
Source | Abstract | Full text | Similar articles




Boisselier B, De Carli E, Rousseau A.
Molecular alterations in pediatric gliomatosis cerebri are similar to those in less invasive forms of pediatric diffuse glioma.
J Neurooncol. 2017 Apr 18. doi: 10.1007/s11060-017-2432-x. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Braunstein S, Raleigh D, Bindra R, Mueller S, Haas-Kogan D.
Pediatric high-grade glioma: current molecular landscape and therapeutic approaches.
J Neurooncol. 2017 Mar 29. doi: 10.1007/s11060-017-2393-0. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Wang Y, Huang N, Li H, Liu S, Chen X, Yu S, Wu N, Bian XW, Shen HY, Li C, Xiao L.
Promoting oligodendroglial-oriented differentiation of glioma stem cell: A repurposing of quetiapine for the treatment of malignant glioma.
Oncotarget. 2017 Mar 21. doi: 10.18632/oncotarget.16400. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Winter SF, Loebel F, Dietrich J.
Role of ketogenic metabolic therapy in malignant glioma: A systematic review.
Crit Rev Oncol Hematol. 2017 Apr;112:41-58. doi: 10.1016/j.critrevonc.2017.02.016. Epub 2017 Feb 20.
Source | Abstract | Full text | Similar articles




LOW-GRADE GLIOMAS


Hayhurst C.
Contemporary management of low-grade glioma: a paradigm shift in neuro-oncology.
Pract Neurol. 2017 Mar 18. pii: practneurol-2017-001604. doi: 10.1136/practneurol-2017-001604. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Ryall S, Tabori U, Hawkins C.
A comprehensive review of paediatric low-grade diffuse glioma: pathology, molecular genetics and treatment.
Brain Tumor Pathol. 2017 Mar 25. doi: 10.1007/s10014-017-0282-z. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





INTRAMEDULLARY SPINAL CORD TUMORS



Luksik AS, Garzon-Muvdi T, Yang W, Huang J, Jallo GI.
Pediatric spinal cord astrocytomas: a retrospective study of 348 patients from the SEER database.
J Neurosurg Pediatr. 2017 Mar 31:1-9. doi: 10.3171/2017.1.PEDS16528. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





MEDULLOBLASTOMA



Stensvold E, Krossnes BK, Lundar T, Due-Tønnessen BJ, Frič R, Due-Tønnessen P, Bechensteen AG, Myklebust TÅ, Johannesen TB, Brandal P.
Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) - a retrospective analysis spanning 40 years of treatment.
Acta Oncol. 2017 May;56(5):698-705. doi: 10.1080/0284186X.2017.1301679. Epub 2017 Mar 21.
Source | Abstract | Full text | Similar articles





PILOCYTIC ASTROCYTOMA



Trunin Y, Golanov AV, Kostjuchenko VV, Galkin M, Konovalov AN.
Pilocytic Astrocytoma Enlargement Following Irradiation: Relapse or Pseudoprogression?
Cureus. 2017 Feb 21;9(2):e1045. doi: 10.7759/cureus.1045.
Source | Abstract | Full text | Similar articles





TUMORS OF THE SELLAR REGION



Burman P, van Beek AP, Biller BM, Camacho-Hübner C, Mattsson AF.
Radiotherapy, Especially at Young Age, Increases the Risk for De Novo Brain Tumors in Patients Treated for Pituitary/Sellar Lesions.
J Clin Endocrinol Metab. 2017 Mar 1;102(3):1051-1058. doi: 10.1210/jc.2016-3402.
Source | Abstract | Full text | Similar articles